Clinical Trial Update: Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors [NA]

View source ↗

Summary

Clinical trial update examining the effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on cardiovascular risk factors in patients with endoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction

Drugs mentioned

• Kaletra (lopinavir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Indiana University | Conditions: Endothelial Dysfunction | NA | Status: COMPLETED